Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
US10039722B2 · kind B2 · utility
0Cited by
25References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 13, 2009 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Oct 28, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating or suppressing oxidative stress diseases and symptoms related to oxidative stress affecting normal electron flow in the cells or caused by reactive oxygen species with redox-active therapeutics. Use of redox-active therapeutics for the reduction, suppression or treatment of oxidative stress induced by chemical agents such as contrast agents and other nephrotoxic agents, by radiation exposure, and by disruptions in the transport of oxygen to tissues, is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.